COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20210222050457N1


Column Value
Trial registration number IRCT20210222050457N1
Full text link
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Fatemeh Shirvanizadeh Arani

Contact
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

dr.shirvanizade@gmail.com

Registration date
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-04-20

Recruitment status
Last imported at : May 4, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Open label

Center
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Male or female patients aged 18 to 75 years with COVID-19 who have been diagnosed with a lung scan, PCR, or clinical examination. Obtaining informed consent from the patient or patient caregiver to participate in the study

Exclusion criteria
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Cancer patients undergoing chemotherapy Patients with immunodeficiency diseases receiving immunomodulators Patients with uncontrolled heart, kidney or liver failure Women who are pregnant or breastfeeding Patients with low level of consciousness who are not able to inhale the spray

Number of arms
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Kashan University of Medical Sciences

Inclusion age min
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

75

Countries
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Moderate/severe disease at enrollment

Severity scale
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

188

primary outcome
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Percentage of arterial oxygen saturation Severity of cough Shortness of breath

Notes
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 1/Phase 2

Arms
Last imported at : April 21, 2021, 2 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 2339, "treatment_name": "Phr-160", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]